EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway

Keeping Current
05/08/2024 37 min
EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway

Listen "EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway"

Descargar episodio Ver en sitio original

Episode Synopsis

How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024.    Credit available for this activity expires: 07/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001409 ?ecd=bdc_podcast_libsyn_mscpedu

More episodes of the podcast Keeping Current

Patient Case Challenge: How Would You Manage This Patient With MASH? 31/12/2025
Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies 24/12/2025
Person-Centered Care in EGFR-Mutated Advanced NSCLC: Optimizing Outcomes and Experiences 19/12/2025
Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy 18/12/2025
How Are ADCs Shaping the Future of Early Breast Cancer Care? Latest Insights and Emerging Strategies 12/12/2025
Pediatric Low-Grade Glioma With BRAF Alterations: Stories, Science, and Strategies 10/12/2025
Hot Topics from Berlin 2025: What Experts Say About the Future of Metastatic Breast Cancer Care 09/12/2025
How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer? 05/12/2025
Staying Ahead of the First Event: Evaluating the Evidence for Early LDL-C Lowering 04/12/2025
Optimizing Outcomes for Patients With IgAN: Novel B-Cell Targeted Therapies and the Changing Treatment Paradigm 02/12/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA